Author | Andrew T. Kuykendall, MD | OncLive

Author | Andrew T. Kuykendall, MD

Articles

Dr. Kuykendall on the Approval of Fedratinib in Myelofibrosis

February 26, 2020

Video

Andrew T. Kuykendall, MD, discusses the additionof fedratinib to the treatment paradigm in myelofibrosis.

Dr. Kuykendall on Choosing Ruxolitinib or Fedratinib in Myelofibrosis

October 17, 2019

Video

Andrew T. Kuykendall, MD, discusses the use of ruxolitinib versus fedratinib in patients with myelofibrosis.

Dr. Kuykendall on the Impact of Ruxolitinib in Myeloproliferative Neoplasms

August 31, 2018

Video

Andrew T. Kuykendall, MD, assistant member, Moffitt Cancer Center, discusses the impact of ruxolitinib (Jakafi) in myeloproliferative neoplasms (MPNs).

x